Document:

ex103.htm

EXHIBIT 10.3

NON-COMPETITION AGREEMENT

This Non-Competition Agreement (the “Agreement”) is entered into as of the 29th day of October 2014, by and between WESBANCO, INC. and WESBANCO BANK, INC. (collectively referred to as the “Buyer”) and CHARLOTTE A. ZUSCHLAG (the “Employee”).

WHEREAS, pursuant to an Agreement and Plan of Merger dated the 29th day of October 2014, by and among Buyer and ESB FINANCIAL CORPORATION and ESB BANK (collectively referred to as the “Seller”) (the “Merger Agreement”), the Seller will merge with and into the Buyer with the Buyer as the continuing entity (the “Merger”);

WHEREAS, the Employee serves as an executive officer of the Seller, and as a condition of the Merger, the Buyer, the Seller and the Employee have agreed to take reasonable measures to maintain and protect the franchise value of the Seller subsequent to the closing of the Merger;

WHEREAS, the Buyer and the Employee agree that in order to maintain the franchise value of the Seller it is important to the Buyer that the Employee remain employed by the Seller through the Effective Date (as defined in the Merger agreement”) of the Merger (the “Commencement Date”), and that thereafter, the Employee will be bound by a non-competition restriction in favor of the Buyer for a period of four (4) years following the Commencement Date in exchange for additional reasonable compensation for assumption of such restrictions and limitations; and

WHEREAS, the parties hereto recognize and acknowledge that the covenants set forth in this Agreement are necessary to protect the business and goodwill of the Seller to be acquired by the Buyer in connection with the Merger;

NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, including the payments to be made to the Employee pursuant to Section 4 of this Agreement, for which the sufficiency of such consideration is hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 1.           Non-competition.  As of the Commencement Date and for a period of four (4) years thereafter (the “Non-compete Period”), the Employee shall not, without the prior written consent of the Buyer, directly or indirectly, whether or not for compensation, engage or invest in, own, manage, operate, finance, control or participate in ownership, management, operation, financing or control of, be employed by, associated with, or in any manner connected with, lend the Employee’s name or any similar name to, lend the Employee’s credit to, or render services or advice to, any business, including a credit union, savings bank, savings and loan association, savings and loan holding company, bank, bank holding company, mortgage company or similar type financial institution (including, without limitation, a de novo financial institution in its organizational phase), or any direct or indirect subsidiary or affiliate of such entity, whose products or activities compete or would compete in whole or in part with the products or activities of the Buyer or its subsidiaries within a thirty (30) miles radius of any office of the Buyer or the Seller during the Non-compete Period (the “Non-compete Area”), provided, however, that the Employee may purchase or otherwise acquire up to (but not more than) two percent of any class of securities of any enterprise (but without otherwise participating in the activities of such enterprise), and provided further that the Employee may borrow from or make deposits in any such enterprise.  The Employee agrees that this covenant is reasonable with respect to its duration, geographical area, and scope.  In the event of a breach by the Employee of any covenant set forth in this Section 1 of this Agreement, the term of such covenant will be extended by the period of the duration of such breach.

 

 

2.           Nonsolicitation.  During the Non-compete Period, the Employee will not, directly or indirectly, either for herself or any other Person (as defined herein), (i) induce or attempt to induce any employee of the Buyer or its subsidiaries to leave the employ of the Buyer or its subsidiaries, (ii) in any way interfere with the relationship between the Buyer or its subsidiaries and any employee of the Buyer or its subsidiaries, (iii) employ, or otherwise engage as an employee, independent contractor or otherwise, any employee of the Buyer or its subsidiaries, or (iv) induce or attempt to induce any customer, supplier, licensee or business relation of the Buyer or its subsidiaries to cease doing business with the Buyer or its subsidiaries, or in any way interfere with the relationship between any customer, supplier, licensee or business relation of the Buyer or its subsidiaries.  During the Non-compete Period, the Employee will not, directly or indirectly, either for herself or any other Person solicit the business of any Person known to the Employee to be a customer of the Buyer or its subsidiaries, whether or not the Employee had personal contact with such Person, with respect to products or activities which compete in whole or in part with the products or activities of the Buyer or its subsidiaries, excluding general solicitations of the public that are not based in whole or in part on any list of customers of the Buyer or any of its subsidiaries.  For purposes of this Agreement, “Person” shall include an individual, trust, estate, corporation, limited liability company, credit union, savings bank, savings and loan association, savings and loan holding company, bank, bank holding company, mortgage company or similar type financial institution, including, without limitation, a de novo financial institution in its organizational phase.

3.           Confidentiality.  The Employee acknowledges and agrees to treat as confidential all information known or obtained by the Employee, whether before or after the date hereof, concerning the Buyer or the Seller, or their respective subsidiaries’ records, properties, books, contracts, commitments and affairs, including but not limited to, information regarding accounts, shareholders, finances, strategies, marketing, customers and potential customers and other information of a similar nature (such information, “Confidential Information”).  The Employee agrees that she will not, at any time, disclose to any unauthorized Persons, or use for her own account or for the benefit of any third party any Confidential Information, whether or not the Confidential Information is embodied in writing or other physical form, without the Buyer’s express written consent, unless and to the extent that such Confidential Information is or becomes generally known to and available for use by the public other than as a result of the Employee’s fault or the fault of any other Person bound by a duty of confidentiality to the Buyer.

4.           Compensation.  In consideration of the covenants contained in this Agreement, the Buyer shall pay to the Employee the sum of One Million Sixty-one Thousand Dollars ($1,061,000.00) in a single lump-sum on the Effective Date of the Merger (the “Payment”).  The Payment shall be subject to applicable tax reporting and may be subject to tax withholding.

 

2

5.           Remedies.  The parties hereto, recognizing that irreparable injury will result to the Buyer, its business and property in the event of the Employee’s breach of this Agreement, hereby consent, in the event of any such breach by the Employee, to an injunction in favor of the Buyer, in addition to any other remedies and damages available, to restrain the violation hereof by the Employee, the Employee’s partners, agents, servants, employers, employees and all persons acting for or with the Employee.  The Employee represents and admits that the Employee’s experience and capabilities are such that the Employee can obtain employment in a business engaged in other industries and/or a different nature than the Buyer, and that the enforcement of a remedy by way of injunction will not prevent the Employee from earning a livelihood.  Nothing herein will be construed as prohibiting the Buyer from pursuing any other remedies available to the Buyer for such breach or threatened breach, including the recovery of damages from the Employee.  The Employee acknowledges that in addition to or in lieu of the Buyer seeking injunctive relief, the Buyer may also seek to recoup in a judicial proceeding any or all amounts paid by the Buyer to the Employee pursuant to Section 4 hereof.  Each of the remedies available to the Buyer in the event of a breach by the Employee shall be cumulative and not mutually exclusive.

6.           Waiver.  The rights and remedies of the parties to this Agreement are cumulative and not alternative.  Neither the failure nor any delay by any party in exercising any right, power or privilege under this Agreement will operate as a waiver of such right, power or privilege, and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege.  To the maximum extent permitted by applicable law, (a) no claim or right arising out of this Agreement can be discharged by one party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing signed by the other party; (b) no waiver that may be given by a party will be applicable except in the specific instance for which it is given; and (c) no notice to or demand on one party will be deemed to be a waiver of any obligation of such party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement.

7.           Successors and Assigns.  This Agreement shall be binding upon the Employee and the Buyer and will inure to the benefit of the Buyer and its affiliates, successors and assigns and the Employee and the Employee’s assigns, estate, heirs and legal representatives.

8.           Governing Law.  This Agreement shall be construed and enforced in accordance with the laws of the Commonwealth of Pennsylvania without regard to conflicts of laws principles.

9.           Severability.  If any provision in this Agreement is declared or determined by any court to be illegal, void or unenforceable, the illegality or unenforceability of such provision shall have no effect upon, and shall not impair, the enforceability or validity of any other provisions in this Agreement.  If any of the covenants set forth in this Agreement are held to be unreasonable, arbitrary or against public policy, such covenants will be considered divisible with respect to scope, time and geographic area, and in such lesser scope, time and geographic area will be effective, binding and enforceable against the Employee.

 

3

10.           Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same agreement.

11.           Termination.  This Agreement shall be terminated and shall have no further force or effect if, and at such time as, the Merger Agreement is terminated.  In the event that the Merger becomes effective and the Payment is made to the Employee, this Agreement and the Non-compete Period herein shall remain in effect between the parties.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

WESBANCO, INC. (“Buyer”)

ATTEST:                                                                By /s/Todd F. Clossin

Its President / CEO

/s/ Linda M. Woodfin

Secretary

WESBANCO BANK, INC. (“Buyer”)

ATTEST:                                                                By /s/ Todd F. Clossin

Its President / CEO

/s/ Linda M. Woodfin

Secretary

  

/s/ Frank D. Martz                                            /s/ Charlotte A. Zuschlag

Witness                                                                CHARLOTTE A. ZUSCHLAG

 

4EX-10.1

 Exhibit 10.1 

Name of Participant:                    

 IMS HEALTH HOLDINGS, INC. 

2014 INCENTIVE AND STOCK AWARD PLAN 

Stock Appreciation Rights Agreement 

Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc.
(the “Company”) has granted to the Participant named above, on the grant date listed on Exhibit A hereto (the “Grant Date”), Stock Appreciation Rights (the “SARs”) that may be exercised with respect to all or a
portion of the number of whole shares of Stock set forth on Exhibit A hereto, subject to the terms and conditions set forth in this Stock Appreciation Rights Agreement (the “Agreement”) and in the Plan. Subject to earlier
termination as provided for herein and in the Plan, the latest date on which the SARs may be exercised is the expiration date specified on Exhibit A hereto (the “Expiration Date”). For the avoidance of doubt, the total number of
shares of Stock underlying the SARs is subject to adjustment pursuant to Section 10 of the Plan. For purposes of this Agreement, “Employer” shall mean the affiliate or subsidiary that employs the Participant (to the extent the
Participant is not directly employed by the Company). 
 1. Nature of SARs. The SARs provide to the Participant a right to receive, upon exercise of
vested SARs in compliance with this Agreement, payment in shares of Stock. The number of shares of Stock that shall be delivered to the Participant upon a valid exercise of the SARs, before any reduction for withholding taxes in accordance with
Section 5, shall be determined by multiplying (i) times (ii) and dividing the resulting product by (iii), where: 
  

	 	(i)	is the number of SARs being exercised; 

  

	 	(ii)	is the excess of (A) the Fair Market Value of one share of Stock on the date of exercise, over (B) the “Base Price Per Share” set forth on Exhibit A; and 

 

	 	(iii)	is the Fair Market Value of one share of Stock on the date of exercise. 

 Unless otherwise determined by the
Company, no fractional shares of Stock will be issued in payment upon the exercise of the SARs. 
 2. Vesting; Exercisability; Manner of Exercise.
The SARs may not be exercised until they have vested. 
 (a) Vesting Schedule. Except as set forth below or in the Plan, the SARs
shall become vested on the vesting dates set forth on Exhibit A hereto, subject to the Participant’s continued Employment through the applicable vesting date. 

(b) Exercisability. Once vested, the SARs shall be exercisable and may be exercised at any time or times prior to the close of business
on the Expiration Date, subject to the provisions hereof and of the Plan and any procedures that the Committee may approve from time to time. Notwithstanding any other provision hereof or of the Plan, no SARs shall be exercisable after the
Expiration Date. 
 (c) Method of Exercise. The Participant may exercise vested SARs by giving notice (in such manner as is
acceptable to the Company) to the Company of his or her election to exercise such SARs. This notice shall specify the number of SARs being exercised. For the avoidance of doubt, the Company may in its sole discretion establish alternative means to
exercise vested SARs, including electronic forms using electronic signatures and interactive voice response systems using PIN numbers, in a manner directed by the Company, and the SARs shall be deemed to be exercised upon fulfillment of such
alternative means. 

  
 1 

 (d) Delivery of Shares Upon Exercise. Promptly following the date the SARs are exercised,
payment shall be made to the Participant in shares of Stock, in accordance with Section 1. Payment may be made by issuance of shares in the name of the Participant and delivery of such shares to the Participant or, in the discretion of the
Company, by issuance and delivery of such shares to a financial institution for the account of the Participant, or in any other commercially reasonable manner as may be determined by the Company. 

(e) Restrictions on Delivered Shares. The Participant’s sales or other dispositions of shares of Stock acquired upon exercise of
the SARs will be subject to applicable restrictions under Company policies applicable to the Participant, including those covering insider trading by employees. 

(f) Cash Settlement. Notwithstanding any provision in this Agreement to the contrary, the Company may, in its sole discretion, settle
the Participant’s SARs in the form of (1) a cash payment to the extent settlement in shares of Stock (i) is prohibited under local law, or (ii) would require the Participant, the Company and/or the Employer to obtain the approval
of any governmental and/or regulatory body in the Participant’s country of residence (and/or country of employment, if different), or (iii) is administratively burdensome; or (2) shares of Stock, but require the Participant to
immediately exercise and sell such shares of Stock (in which case, as a condition to the grant of this award, the Participant hereby expressly authorizes the Company to issue sales instructions on the Participant’s behalf). 

3. Use of Certain Defined Terms. Capitalized terms used in this Agreement shall have the meaning specified in the Plan, unless a different meaning is
specified herein. In the event of a conflict between the terms and conditions of this Agreement and the Plan, the Plan shall control, except as expressly provided in Section 4 herein. The terms set forth below shall have the following meanings:

 (a) “Disability” shall mean: (i) If the Participant is a party to an employment or severance-benefit agreement that
contains a definition of “Disability,” the definition set forth in such agreement shall apply with respect to the Participant under the Plan for so long as such agreement is in effect; and (ii) otherwise, a disability that would
entitle the Participant to long-term disability benefits under the Company’s long-term disability plan in which the Participant participates. 

(b) “Employment” shall mean the Participant’s employment by, or other service to, the Company or any of its subsidiaries. 

(c) “Retirement” shall mean retirement from active Employment after attaining age 65, or after attaining age 55 and completion of at
least five (5) years of Employment with the Company or any of its subsidiaries (including any acquired entity with respect to which the Committee has determined to credit pre-acquisition service for this purpose). 

4. Termination of Service. If the Participant’s Employment ceases for any reason, the SARs, to the extent not already then vested, will be
immediately forfeited and any vested SARs will be treated as follows: 
 (a) Generally. Subject to subsections (b), (c) and
(d) below, the SARs, to the extent vested immediately prior to the cessation of the Participant’s Employment, will remain exercisable until the earlier of (i) 90 days following cessation of Employment or (ii) the Expiration Date,
and, unless previously exercised, will thereupon immediately terminate. 
 (b) Disability, Death or Retirement. In the event of a
cessation of the Participant’s Employment by the Company by reason of the Participant’s Disability or due to the Participant’s death or Retirement, the SARs, to the extent vested immediately prior to such cessation of Employment, will
remain exercisable until the earlier of (i) the first anniversary of such cessation of Employment, and (ii) the Expiration Date, and, unless previously exercised, will thereupon immediately terminate. 

(c) Termination for Cause. The SARs, whether or not vested, will terminate immediately upon a cessation of the Participant’s
Employment if such cessation of Employment has resulted in connection with an act or failure to act constituting Cause. 

  
 2 

 (d) Other Terminations of SARs. Other provisions of the Plan and this Agreement, including
Sections 7 and 8, may result in the termination of unexercised SARs prior to the Expiration Date. 
 5. Income Tax and Social Insurance Withholding.
Regardless of any action the Company and/or the Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and/or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related
withholding (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Employer
(a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the SARs, including the grant of the SARs, the vesting of the SARs, the exercise of the SARs, the subsequent sale of
any shares of Stock (or cash) acquired pursuant to the SARs and the receipt of any dividends and (b) do not commit to structure the terms of the grant or any aspect of the SARs to reduce or eliminate the liability for Tax-Related Items. Prior
to the delivery of shares of Stock upon exercise of the SARs, if the Participant’s country of residence (and/or the Participant’s country of employment, if different) requires withholding of Tax-Related Items, unless otherwise determined
by the Committee, the Company shall withhold a sufficient number of whole shares of Stock otherwise issuable upon exercise of the SARs that have an aggregate Fair Market Value sufficient to pay the minimum Tax-Related Items required to be withheld
with respect to the shares of Stock delivered upon such exercise of the SARs. The cash equivalent of the shares of Stock withheld will be used to settle the obligation to withhold the Tax-Related Items. Alternatively, the Company and/or Employer may
withhold the minimum Tax-Related Items required to be withheld with respect to the shares of Stock in cash from the Participant’s regular salary and/or wages, or other amounts payable to the Participant. In the event the withholding
requirements are not satisfied through the withholding of Stock or through the Participant’s regular salary and/or wages or any other amounts payable to the Participant by the Employer, no shares of Stock will be issued to the Participant (or
the Participant’s estate) upon exercise of the SARs unless and until satisfactory arrangements (as determined by the Committee) have been made by the Participant with respect to the payment of any Tax-Related Items that the Company or the
Participant’s Employer determines, in its sole discretion, must be withheld or collected with respect to such SARs. By accepting the SARs, the Participant expressly consents to the withholding of shares of Stock and/or withholding from the
Participant’s regular salary and/or wages or other amounts payable to the Participant as provided for hereunder. All other Tax-Related Items related to the SARs and any shares of Stock delivered in payment thereof are the Participant’s
sole responsibility. 
 6. Transferability. The SARs and this Agreement are personal to the Participant, are non-assignable and are not transferable
in any manner, by operation of law or otherwise, other than by will or the laws of descent and distribution or as permitted by the Committee. Any attempted transfer, assignment, pledge or other disposition of the SARs or of any rights granted under
this Agreement that is contrary to the provisions of the Plan or this Section 6 shall be null and void. The SARs are exercisable, during the Participant’s lifetime, only by the Participant or his or her legal guardian, if any, and
following the Participant’s death, only by the Participant’s legal representative or legatee, and, if the Committee permits a transfer of the SARs, by the permitted transferee. A permitted transferee will have the rights of the Participant
with regard to any transferred SARs, subject to any limitations imposed by the Company as a condition of permitting the transfer or otherwise. 
 7.
Forfeiture; Recovery of Compensation. 
 (a) The Committee may cancel, rescind, withhold or otherwise limit or restrict the SARs or
delivery of shares upon exercise of the SARs at any time if the Participant is not in compliance with all applicable provisions of this Agreement and the Plan (including, but not limited to, Section 2(e), Section 6 and Section 9).

 (b) By accepting the SARs, the Participant expressly acknowledges and agrees that his or her rights, and those of any permitted
transferee of the SARs, under the SARs, including to any Stock acquired under the SARs or proceeds from the disposition thereof, are subject to Section 9 of the Plan (including any successor provision). Nothing in the preceding sentence shall
be construed as limiting the general application of Section 10(e) of this Agreement. 

  
 3 

 8. Other Undertakings. To protect the interests of the Company and its direct and indirect affiliates and
subsidiaries (individually, an “IMS Company” and collectively, the “IMS Companies”), including the confidential information of the IMS Companies and the confidential information of their respective customers, data suppliers,
prospective customers and other companies with which the IMS Companies have a business relationship, and in consideration of the covenants and promises and other valuable consideration described in this Agreement, the Company and the Participant
agree as follows: 
 (a) The Participant acknowledges and agrees that he or she is bound by the confidentiality and other covenants
contained in one or more restrictive covenant and confidentiality agreements that he or she has executed with an IMS Company, which covenants and agreements are incorporated herein by reference and shall survive any exercise, expiration, forfeiture
or other termination of this Agreement or the SARs issuable hereunder. The Participant also acknowledges and agrees that the Company shall be an affiliate for purposes of such restrictive covenant and confidentiality agreements. 

(b) The Participant acknowledges that the opportunity to participate in the Plan and the financial benefits that may accrue from such
participation, is good, valuable and sufficient consideration for the following: 
  

	 	(i)	The Participant acknowledges and agrees that he or she is and will remain bound by the non-competition, non-solicitation and other covenants contained in the restrictive covenant and confidentiality agreement(s) that he
or she has executed with any of the IMS Companies to the fullest extent permitted by law. 

  

	 	(ii)	The Participant further acknowledges and agrees that the period during which the non-competition and non-solicitation covenants in such agreement(s) will apply following a termination of Employment shall be extended
from twelve (12) months to eighteen (18) months; provided, however, that the remedies available for breach of any non-competition or non-solicitation covenants during such extended six-month period shall be limited to the
following: (x) to the extent then outstanding, the forfeiture of the SARs for no consideration, and (y) to the extent the SARs have been exercised on or after the date that is 18 months before Participant’s cessation of Employment,
with respect to the shares of Stock issued upon such exercise (including shares withheld for taxes), the Participant shall pay to the Company an amount equal to (A) the aggregate fair market value of such shares of Stock as of the date of
exercise, plus (B) the excess, if any, of the aggregate proceeds of all sales of such shares of Stock over the amount described under subsection (A) above. (For this purpose, the Participant’s earliest sales of shares following such
exercise will be deemed sales of the shares acquired upon such exercise.) The Company shall also be entitled to the foregoing remedies in the event of a material breach of any confidentiality, non-disclosure or other similar covenant contained in
the restrictive covenant and confidentiality agreement(s) that the Participant has executed with an IMS Company. 

  

	 	(iii)	The Participant further acknowledges and agrees to the Company’s application, implementation and enforcement of (a) such policy set forth in Section 8(b)(ii) of this Agreement and (b) any provision
of applicable law or Company policy relating to cancellation, recoupment, rescission or payback of compensation and expressly agrees that the Company may take such actions as are necessary to effectuate such policy (as applicable to the Participant)
or applicable law without further consent or action being required by the Participant. For purposes of the foregoing, the Participant expressly and explicitly authorizes the Company to issue instructions, on the Participant’s behalf, to any
brokerage firm and/or third party administrator engaged by the Company to hold Participant’s shares of Stock and other amounts acquired under the Plan to re-convey, transfer or otherwise return such shares of Stock and/or other amounts to the
Company. To the extent that the terms of this Agreement and such policy conflict, the terms of such policy shall prevail. 

  
 4 

	 	(iv)	By accepting the SARs, the Participant consents to one or more deductions from any amounts any IMS Company owes the Participant from time to time in an aggregate amount equal to all amounts described in subsection
(ii) above, to the extent such deductions are permitted by applicable law. Any such deduction from an amount that constitutes a deferral of compensation under Code Section 409A may only take place at the time the amount would otherwise be
payable to the Participant, except to the extent permitted by Code Section 409A. 

 9. Governing Law and Venue. 

(a) This Agreement and all claims arising out of or based upon this Agreement or relating to the subject matter hereof shall be governed by
and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other
jurisdiction. 
 (b) Any legal proceeding arising out of this Plan or this Agreement shall be brought exclusively in the Federal or State
courts located in the State of Delaware. The Participant agrees to submit to personal jurisdiction and to venue in those courts. The Participant further agrees to waive all legal challenges and defenses to the appropriateness of Delaware as the site
of any such legal proceeding and to the application of the laws of the State of Delaware and any applicable Federal laws. 
 10. Miscellaneous. 

(a) Notice hereunder shall be given to the Company at its principal place of business, and shall be given to the Participant at the last
address shown in the Company’s records, or in either case at such other address as one party may subsequently furnish to the other party in writing. 

(b) Notwithstanding any provisions of Agreement to the contrary, the SARs shall be subject to any special terms and conditions for the
Participant’s country of residence (and/or country of employment, if different) set forth in the addendum to this Agreement (the “Addendum”). Further, if the Participant transfers residency and/or employment to another country set
forth in the Addendum, at the time of transfer, any special terms and conditions for such country will apply to the Participant to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is
necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the SARs and the Plan (or the Company may establish alternative terms and conditions as may be necessary or
advisable to accommodate the Participant’s transfer). In all circumstances, any applicable Addendum shall constitute part of the Agreement. 

(c) The Company reserves the right to impose other requirements on the SARs, any shares of Stock acquired pursuant to the SARs and the
Participant’s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations or to facilitate the
operation and administration of the SARs and the Plan. Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing. 

(d) The issuance of Stock upon exercise of the SARs will be contingent upon the Company’s receipt of any agreement, statement or other
evidence that the Company and/or the Committee may require to satisfy itself that the issuance of Stock pursuant to the exercise of the SARs and any subsequent resale of the shares of Stock will be in compliance with all applicable laws and
regulations and with the requirements hereof and of the Plan. The determination of the Committee as to such compliance shall be final and binding on the Participant. The Participant shall not be deemed to be the holder of, or to have any dividend or
other rights of a holder with respect to, any shares of Stock subject to the SARs unless and until the SARs shall have been exercised pursuant to the terms hereof and of the Plan, the Company shall have issued and delivered the shares of Stock to
the Participant in accordance with Sections 1 and 2 of this Agreement, and the Participant’s name shall have been entered as the stockholder of record on the books of the Company (if an alternative

  
 5 

 
method of delivery is elected by the Company under Section 2, Participant will be required to take appropriate steps to cause any nominee to transfer shares into the name of the Participant
in order for Participant to become a record holder of the shares). Thereupon, the Participant shall have full voting, dividend and other ownership rights with respect to such shares of Stock. 

(e) This Agreement is subject in its entirety to the provisions of the Plan, which are incorporated herein by reference. A copy of the Plan as
in effect on the Grant Date has been furnished to the Participant. By accepting this award of SARs, the Participant agrees to be bound by the terms of the Plan and this Agreement. 

(f) The Agreement, the Addendum (if applicable) and the Plan constitute the entire understanding between the Participant and the Company
regarding the SARs, and any prior agreements, commitments or negotiations concerning the SARs are superseded. 
 (g) Any provision of this
Agreement or the Addendum that is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this Section, be ineffective to the extent of such invalidity, illegality or unenforceability, without
affecting in any way the remaining provisions thereof in such jurisdiction or rendering that or any other provisions of this Agreement and the Addendum invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed
invalid, illegal or unenforceable because its scope is considered excessive, such covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and
enforceable. No waiver of any provision or violation of this Agreement or the Addendum by the Company shall be implied by the Company’s forbearance or failure to take action. 

11. Data Privacy. The Company and the Employer hereby notify the Participant of the following in relation to the Participant’s personal data and
the collection, processing and transfer of such data in relation to the award of the SARs and the Participant’s participation in the Plan pursuant to applicable personal data protection laws. The collection, processing and transfer of the
Participant’s personal data is necessary for the Company’s administration of the Plan and the Participant’s participation in the Plan, and the Participant’s denial and/or objection to the collection, processing and transfer of
personal data may affect the Participant’s ability to participate in the Plan. As such, the Participant voluntarily acknowledges, consents and agrees (where required under applicable law) to the collection, use, processing and transfer of
personal data as described herein. The Company and the Employer hold certain personal information about the Participant, including (but not limited to) the Participant’s name, home address and telephone number, date of birth, social security
number or other employee identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all SARs or any other entitlement to shares of Stock awarded, canceled, purchased, vested,
exercised, unvested or outstanding in the Participant’s favor for the purpose of managing and administering the Plan (“Data”). The Data may be provided by the Participant or collected, where lawful, from third parties, and the Company
and the Employer will process the Data for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan. The data processing will take place through electronic and non-electronic means according
to logics and procedures strictly correlated to the purposes for which the Data is collected and with confidentiality and security provisions as set forth by applicable laws and regulations in the Participant’s country of residence. Data
processing operations will be performed in a manner that minimizes the use of personal and identification data when such operations are unnecessary for the processing purposes sought. The Data will be accessible within the Company’s
organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and for the Participant’s participation in the Plan. The Company and the Employer will transfer Data as necessary
for the purpose of implementation, administration and management of the Participant’s participation in the Plan, and the Company and/or the Employer may each further transfer Data to any third parties assisting the Company in the
implementation, administration and management of the Plan. These recipients may be located in the European Economic Area, the United States or elsewhere throughout the world. The Participant hereby authorizes (where required under applicable law)
the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for purposes of implementing, administering and managing the Participant’s participation in the Plan, including any requisite transfer of such
Data as may be required for the administration of the Plan and/or the subsequent holding of 

  
 6 

 
shares of Stock on the Participant’s behalf to a broker or other third party with whom the Participant may elect to deposit any shares of Stock acquired pursuant to the Plan. The Participant
may, at any time, exercise the Participant’s rights provided under applicable personal data protection laws, which may include the right to (a) obtain confirmation as to the existence of the Data, (b) verify the content, origin and
accuracy of the Data, (c) request the integration, update, amendment, deletion, or blockage (for breach of applicable laws) of the Data, and (d) oppose, for legal reasons, the collection, processing or transfer of the Data that is not
necessary or required for the implementation, administration and/or operation of the Plan and the Participant’s participation in the Plan. The Participant may seek to exercise these rights by contacting the Participant’s local human
resources manager. 
 12. Acknowledgements and Acceptance 

In accepting the SARs, the Participant acknowledges and agrees that: 

(a) The Participant will have no claim or entitlement (i) to compensation or damages in consequence of the termination of Employment for
any reason whatsoever and whether or not in breach of contract, insofar as such claim or entitlement arises or may arise from his or her ceasing to have any rights under the Plan or this Agreement, (ii) to exercise the SARs as a result of such
termination of Employment, except as expressly provided in this Agreement, or (iii) from the loss or diminution in value of the SARs or shares of Stock deliverable or delivered upon exercise of the SARs (including due to any delay between
initiation of the exercise process and delivery of shares); and, upon the grant of the SARs and in partial consideration for his or her participation in the Plan and this Agreement, the Participant shall be deemed irrevocably to have waived any such
claim or entitlement. 
 (b) If the Participant does not want to accept the SARs on the terms and conditions set out in this Agreement, the
Plan and/or any related documents, the Participant may choose the “Decline” button. The SARs will then be cancelled and no other benefit will be due to the Participant in lieu thereof. If Participant does not “Decline” the SARs
within thirty (30) days from the Grant Date, the Participant shall be deemed to have accepted the SARs and shall be deemed to have agreed to the terms and conditions set out in this Agreement, the Plan and/or any related documents. 

(c) Neither the grant of the SARs, nor the issuance of Stock upon exercise of the SARs, will give the Participant any right to be retained in
the employ or service of the Company or any of its subsidiaries, affect the right of the Company or any of its subsidiaries to discharge (as may otherwise be permitted under local law) or discipline the Participant at any time or affect any right of
the Participant to terminate his or her Employment at any time. 
 (d) The Participant acknowledges and agrees that the Plan is
discretionary in nature and limited in duration, and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. 

(e) The grant of SARs is a one-time benefit and does not create any contractual or other right for the Participant to receive a grant of SARs
or benefits in lieu of SARs in the future. The terms of future Awards of SARs, if any, will be determined by the Company in its sole discretion, including, but not limited to, the form and timing of such Award, the number of shares of Stock subject
to the SARs, and the vesting and exercise provisions applicable to the SARs. 
 (f) The headings preceding the text of the sections hereof
are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect. 

(g) The grant of the SAR is not intended to be a public offering of securities in the Participant’s country of residence (and country of
employment, if different). The Company has not submitted any registration statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the grant of the SAR is not subject to the
supervision of the local securities authorities. No employee of the Company or any of the Company’s subsidiaries is permitted to advise the Participant on whether the Participant should acquire Stock by exercising the SAR under the Plan.
Investment 

  
 7 

 
in Stock involves a degree of risk. Before deciding to acquire Stock by exercising the SAR, the Participant should carefully consider all risk factors relevant to the acquisition of Stock under
the Plan and the Participant should carefully review all of the materials related to the SAR and the Plan. In addition, the Participant should consult with the Participant’s personal advisor for professional investment advice. 

(h) The Participant acknowledges and agrees that it is the Participant’s express intent that the Agreement, the Exhibit, the Addendum and
the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the award, be drawn up in English. If the Participant has received the Agreement, the Exhibit, the Addendum and the Plan or any other
documents related to the award translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version shall control. 

(i) As a condition to the SAR, the Participant agrees to repatriate all payments attributable to the Stock and/or cash acquired under the Plan
in accordance with local foreign exchange rules and regulations in the Participant’s country of residence (and country of employment, if different). In addition, the Participant also agrees to take any and all actions, and consents to any and
all actions taken by the Company and its subsidiaries and affiliates and/or the Employer, as may be required to allow the Company and its subsidiaries and affiliates or the Employer to comply with local laws, rules and regulations in the
Participant’s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal obligations under local laws, rules and
regulations in the Participant’s country of residence (and country of employment, if different). 
 (j) By choosing the
“Accept” button, the Participant accepts the SARs as described above and the terms and conditions set out in this Agreement, the Plan and any related documents. Copies of the Plan and such related documents are being provided to
Participant as part of this Agreement. 
  

	
	IMS HEALTH HOLDINGS, INC.
	
	Ari Bousbib
	Chairman and Chief Executive Officer

  
 8 

 STOCK APPRECIATION RIGHTS AGREEMENT 

PURSUANT TO IMS HEALTH HOLDINGS, INC. 

2014 INCENTIVE AND STOCK AWARD PLAN 

Exhibit A 
  

			
	 Name of Participant:
	  	[insert Name of Participant]
		
	 No. of shares of Stock subject to
 the Stock
Apprecitation Rights:
	  	[insert No. of Shares]
		
	 Base Price Per Share:
	  	$[insert per share base price]
		
	 Grant Date:
	  	[insert Grant Date]
		
	 Expiration Date:
	  	[insert date 10 years from Grant Date]

 Vesting Schedule: 
  

			
	 Number of

SARs Exercisable
	  	Vesting Date
	
[                ]      
      (25%)
	  	[                    ]
	
[                ]      
      (25%)
	  	[                    ]
	
[                ]      
      (25%)
	  	[                    ]
	
[                ]      
      (25%)
	  	[                    ]

  
 9 

 IMS HEALTH HOLDINGS INC. 

2014 Incentive and Stock Award Plan 

ADDENDUM TO 
 STOCK
APPRECIATION RIGHTS AGREEMENT 
 In addition to the terms of the Plan and the Agreement, the SARs are subject to the following additional terms and
conditions (the “Addendum”). All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the Plan and this Agreement. Pursuant to Section 10(c) of the Agreement, if the Participant transfers the
Participant’s residence and/or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to the Participant to the extent the Company determines, in its sole
discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the SAR and the Plan (or the Company may establish
alternative terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer). 
 AUSTRALIA 

1. SAR Conditioned on Satisfaction of Regulatory Obligations. If the Participant is (a) a director of a subsidiary
incorporated in Australia, or (b) a person who is a management-level executive of a subsidiary incorporated in Australia and who also is a director of a subsidiary incorporated outside of the Australia, the grant of the SARs is conditioned upon
satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) and the Corporations Amendment (Improving Accountability on Termination Payments) Act in Australia. 

2. Right to Exercise SAR. Notwithstanding anything in the Agreement or the Plan to the contrary, if the SAR vests when the fair
market value per share of Stock is equal to or less than the exercise price, the Participant may not exercise the vested SAR until the first business day following the business day in which the fair market value per share of Stock exceeds the
exercise price of the SAR. For the avoidance of doubt, this provision shall apply to any SAR held by a Participant who transfers to Australia after the SAR is granted, as determined by the Committee in its sole discretion. 

CANADA 
 1. Exercise Procedures
– No Payment with Stock. Notwithstanding any provision in the Agreement or the Plan, if the Participant is resident in Canada, the Participant may not pay the Exercise Price for the shares of Stock for which the SAR is being exercised
by tendering shares of Stock already owned by the Participant. 
 2. Use of English Language. If the Participant is a resident
of Quebec, by accepting the SARs, the Participant acknowledges and agrees that it is the Participant’s wish that the Agreement, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted
pursuant to the award, either directly or indirectly, be drawn up in English. 
 Utilisation de l’anglais. Si le
bénéficiaire est un résident du Québec, en acceptant l’Attribution, le bénéficiaire reconnaît et accepte avoir requis que le Contrat, la présente Annexe, ainsi que tous autres documents,
avis et procédures judiciaires, exécutés, donnés ou intentés en vertu de, ou liés directement ou indirectement à, la présente Attribution soient rédigés en anglais. 

  
 10 

 FRANCE 

1. English Language. By accepting the SARs, the Participant acknowledges and agrees that it is the Participant’s wish that
the Agreement, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to the award, either directly or indirectly, be drawn up in English. 

Langue anglaise. Le bénéficiaire admet et convient que c’est l’intention exprès du
bénéficiaire que l’Accord, le Plan et tous les autres documents, remarque et les poursuites judiciaires entrées, données ou instituées conformément à l’SAR, être établi dans
l’anglais. Si le bénéficiaire a reçu l’Accord, le Plan ou autres documents rattachés à l’SAR traduite dans une langue autre que l’anglais et si le sens de la version traduite est
différent que la version anglaise, la version anglaise contrôlera. 
 HONG KONG 

1. Important Notice. WARNING: The contents of the Agreement, the Addendum, the Plan, and all other materials pertaining to the
SARs and/or the Plan have not been reviewed by any regulatory authority in Hong Kong. The Participant is hereby advised to exercise caution in relation to the offer thereunder. If the Participant has any doubts about any of the contents of the
aforesaid materials, the Participant is encouraged to obtain independent professional advice. 
 2. Nature of the Plan. The
Company specifically intends that the Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (“ORSO”). To the extent any court, tribunal or legal/regulatory body in Hong
Kong determines that the Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the SARs shall be null and void. 

MEXICO 
 1. Commercial
Relationship. The Participant expressly recognizes that the Participant’s participation in the Plan and the Company’s grant of SARs does not constitute an employment relationship between the Participant and the Company. The
Participant has been granted the SARs as a consequence of the commercial relationship between the Company and the Employer, and the Employer is the Participant’s sole employer. Based on the foregoing, (a) the Participant expressly
recognizes that the Plan and the benefits the Participant may derive from the Participant’s participation in the Plan does not establish any rights between the Participant and the Employer that employs the Participant, (b) the Plan and the
benefits the Participant may derive from the Participant’s participation in the Plan are not part of the employment conditions and/or benefits provided by the Employer that employs the Participant, and (c) any modifications or amendments
of the Plan by the Company, or a termination of the Plan by the Company, shall not constitute a change or impairment of the terms and conditions of the Participant’s employment with the Employer that employs the Participant. 

2. Extraordinary Item of Compensation. The Participant expressly recognizes and acknowledges that the Participant’s
participation in the Plan is a result of the discretionary and unilateral decision of the Company, as well as the Participant’s free and voluntary decision to participate in the Plan in accord with the terms and conditions of the Plan, the
Agreement, and this Addendum. As such, the Participant acknowledges and agrees that the Company may, in its sole discretion, amend and/or discontinue the Participant’s participation in the Plan at any time and without any liability. The value
of the SARs is an extraordinary item of compensation outside the scope of the Participant’s employment contract, if any. The SARs are not part of the Participant’s regular or expected compensation for purposes of calculating any severance,
resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Employer. 

  
 11 

 BY SIGNING BELOW, THE PARTICIPANT ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE PROVISIONS OF THE PLAN, THE
AGREEMENT AND THIS ADDENDUM. 
 PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN [INSERT DATE] TO [INSERT]. 

 

					
	  
	  	 	  	  

	Participant Signature	  		  	Participant Name (Printed)
			
	  
	  		  	
	Date	  		  	

 NETHERLANDS 

1. Waiver of Termination Rights. The Participant waives any and all rights to compensation or damages as a result of any
termination of employment for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the Plan, or (b) the Participant ceasing to have rights under,
or ceasing to be entitled to SARs or other awards under the Plan as a result of such termination. 
 SINGAPORE 

1. Qualifying Person Exemption. The grant of the SARs under the Plan is being made pursuant to the “Qualifying Person”
exemption” under section 273(1)(f) of the Securities and Futures Act (Chapter 289) (“SFA”). The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. The Participant should note that, as a
result, the SARs are subject to section 257 of the SFA and the Participant will not be able to make (a) any subsequent sale of Stock in Singapore or (ii) any offer of such subsequent sale of shares of Stock subject to
the SARs in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2011 Ed.). 

SPAIN 
 1. Acknowledgement of
Discretionary Nature of the Plan; No Vested Rights. In accepting the SARs, the Participant acknowledges that the Participant consents to participation in the Plan and has received a copy of the Plan. The Participant understand that the
Company has unilaterally, gratuitously and in its sole discretion granted SARs under the Plan to individuals who may be employees of the Company or its subsidiaries throughout the world. The decision is a limited decision that is entered into upon
the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its subsidiaries on an ongoing basis. Consequently, the Participant understands that the SARs are granted on the assumption and
condition that the SARs and Stock acquired upon exercise of the SARs shall not become a part of any employment contract (either with the Company or any of its subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes
(including severance compensation) or any other right whatsoever. In addition, the Participant understands that this grant would not be made to the Participant but for the assumptions and conditions referenced above. Thus, the Participant
acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason; the SARs shall be null and void. 

The Participant understands and agrees that, as a condition of the grant of the SARs, any unvested SARs as of the date the Participant ceases active
employment and any vested portion of the SARs not exercised within the post-termination exercise period set out in the Agreement will be forfeited without entitlement to the underlying shares of Stock or to any amount of indemnification in the event
of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers’ Statute or (ii) relocation under Article 40 of the Workers’ Statute.
The Participant acknowledges that the Participant has read and specifically accepts the conditions referred to in the Agreement regarding the impact of a termination of employment on the Participant’s SARs. 

  
 12 

 BY SIGNING BELOW, THE PARTICIPANT ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE PROVISIONS OF THE PLAN, THE
AGREEMENT AND THIS ADDENDUM. 
 PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN [INSERT DATE] TO [INSERT]. 

 

					
	  
	  	 	  	  

	Participant Signature	  		  	Participant Name (Printed)
			
	  
 Date
	  		  	

 UNITED KINGDOM 

1. Exercise Procedures – No Payment with Stock. Notwithstanding anything in Section 5 of the Agreement to the contrary,
if the Participant is resident in the United Kingdom, the Participant shall not be permitted to use existing shares of Stock for exercising the SARs and paying the Exercise Price. 

2. Income Tax and Social Insurance Contribution Withholding. The following provision supplements Section 5 of the
Agreement: 
 If payment or withholding of the income tax due in connection with the SARs is not made within ninety (90) days after the end of the UK
tax year in which the event giving rise to the income tax liability occurs or such other period specified in section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 (the “Due Date”), the amount of any uncollected income
tax shall constitute a loan owed by the Participant to the Employer, effective as of the Due Date. The Participant acknowledges and agrees that the loan will bear interest at the then-current official rate of Her Majesty’s Revenue &
Customs (“HMRC”), it shall be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Agreement. Notwithstanding the foregoing, if the Participant is a
director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the Participant will not be eligible for a loan from the Company or Employer to cover the income tax
liability. In the event that the Participant is a director or executive officer and income tax is not collected from or paid by the Participant by the Due Date, the amount of any uncollected income tax will constitute a benefit to the Participant on
which additional income tax and national insurance contributions (“NICs”) will be payable. The Participant will be responsible for reporting any income tax and for reimbursing the Company or Employer the value of any employee NICs due on
this additional benefit. 
 3. Exclusion of Claim. The Participant acknowledges and agrees that the Participant shall have no
entitlement to compensation or damages insofar as such entitlement arises or may arise from the Participant’s ceasing to have rights under or to be entitled to exercise the Participant’s SAR as a result of such termination (whether the
termination is in breach of contract or otherwise), or from the loss or diminution in value of the Participant’s SAR. Upon the grant of the Participant’s SAR, the Participant shall be deemed to have waived irrevocably any such entitlement.

 *    *    *    *    * 

  
 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]